Full title: Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

Author/creator: Neoptolemos, John P, Prof, Palmer, Daniel H, Prof, Ghaneh, Paula, Prof, Psarelli, Eftychia E, MSc, Valle, Juan W, MD, Halloran, Christopher M, MD, Faluyi, Olusola, MD, O'Reilly, Derek A, MD, Cunningham, David, Prof, Wadsley, Jonathan, Prof, Darby, Suzanne, MD, Meyer, Tim, Prof, Gillmore, Roopinder, MD, Anthoney, Alan, MD, Lind, Pehr, MD, Glimelius, Bengt, MD, Falk, Stephen, MD, Izbicki, Jakob R, Prof, Middleton, Gary William, MD, Cummins, Sebastian, MD, Ross, Paul J, MD, Wasan, Harpreet, MD, McDonald, Alec, MD, Crosby, Tom, MD, Ma, Yuk Ting, MD, Patel, Kinnari, MD, Sherriff, David, FRCR, Soomal, Rubin, MD, Borg, David, MD, Sothi, Sharmila, MD, Hammel, Pascal, Prof, Hackert, Thilo, MD, Jackson, Richard, PhD, Büchler, Markus W, Prof, European Study Group for Pancreatic Cancer.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1876470020

Language: English

Formats: Articles

Publishers: England: Elsevier Ltd

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1876470020